With a pandemic sweeping the globe, it can be easy to forget about sun safety. But it’s a dangerous threat we face and being vigilant about skin cancer risk factors is important. It may seem easy to cover up in winter, since it’s so cold – but your face, head
The situation around the COVID-19 pandemic is rapidly changing. Like many other businesses, TROG Cancer Research is adapting to this situation to ensure the safety and welfare of staff, whilst aiming to limit interruptions to our business operations. Some of those measures include: All TROG Cancer Research Staff are
The coronavirus health pandemic is a challenging time for us all – personally and professionally. We know that the changes and safety precautions required as a result of the pandemic have had significant impacts on the way we operate clinical trials – those that are underway, set to start
There is nothing scarier than hearing the words “you have cancer”. Unfortunately, more than 300 people in Australia hear these words every day and have to go through the difficult task of repeating them to loved ones, friends and even work colleagues. Along with undergoing surgery, chemotherapy or radiation therapy, among
Over three decades, TROG Cancer Research has facilitated hundreds of clinical trials that have involved more than 14,500 cancer patients and helped improve the outcome and quality of life for thousands more cancer patients globally. Over that time, the prognosis of cancer patients has improved considerably: in the 1980s,
TROG Cancer Research will work with clinicians at Townsville Hospital, as well as other national experts, to implement a research program aimed at understanding how to best use new MRI LINAC technology to benefit cancer patients. Weighing in at 8,000 kilograms, the MRI LINAC is one of the most
TROG Cancer Research is currently in the final year of their 2017-2019 strategic plan. On Friday 2 August 2019, we held a strategic planning meeting with key stakeholders to discuss the direction and focus for the upcoming three years. The workshop facilitated by Ms Alison Evans, Health Consultant, was
TROG Cancer Research are proud to announce that we have two new additions to the TROG Cancer Research Board of Directors. Joining our team is Professor Annette Haworth and Denis Byron. Appointed as a non-Radiation Oncology Director, Annette is an ACPSEM accredited medical physicist who brings more than twenty years of
For over 30 years, Trans-Tasman Radiation Oncology Group has been dedicated to improving the way radiation medicine is delivered to cancer patients with ongoing scientific research, clinical trials, and cutting-edge technology.
Latest News
Keep up to date with TROG news, subscribe to our community newsletter.
ABN: 45 132 672 292
